UAB Gurtam (commonly "Gurtam"; also registered as Gurtam UAB) is a privately held, founder-led software company founded in 2002. Its headquarters are at Ozo g. 12A, Vilnius, Lithuania, with additional offices in Boston, Dubai, and Tbilisi. The company moved its head office from Minsk, Belarus to Vilnius in 2022. Gurtam is not publicly traded; no parent company is disclosed. Lithuanian registry data (rekvizitai.vz.lt) lists roughly 235 insured employees in Lithuania and 2024 sales revenue of about €40.2M, with net profit of ~€10.5M; company materials cite 300+ staff overall and describe 99% of turnover as export-driven.
Gurtam develops software for GPS tracking, fleet management, and IoT telematics, sold largely through a partner/reseller network rather than directly. Its three named product lines are Wialon, a cloud and on-premise fleet-management/telematics platform (the flagship); flespi, an API-first telematics backend/hub for connecting hardware to business systems; and GPS-Trace, a free personal GPS tracking service. The company is hardware-agnostic, supporting thousands of third-party tracker models, and reports millions of connected vehicles across 150+ countries. These are genuine commercial operations, not a licensing shell.
Patent-litigation posture: Gurtam appears in the tracked data only as a defendant (0 plaintiff cases, 2 defendant cases), both in the Eastern District of Texas and both filed 2025-06-25 — consistent with an operating company defending against an outside patent assertion rather than a two-way litigant. The two entries reflect Fleet Connect Solutions LLC v. UAB Gurtam (lead case 2:25-cv-00661 and a related member case, 2:25-cv-00796).
Context: Plaintiff Fleet Connect Solutions LLC is characterized in public sources as a non-practicing entity asserting an acquired telematics/fleet-management portfolio (Unified Patents identifies it as an Empire IP entity). The Gurtam suits are part of a broad campaign against fleet-tracking and telematics vendors. Stanford's NPE Litigation Database lists asserted patents including US 6,647,270; 6,961,586; 7,092,723; 7,206,837; 7,593,751; 7,741,968; and 8,494,581. Docket activity includes a joint motion to stay pending ex parte reexamination.